Skip to main content
Mindful Health Solutions logo

Mindful Health Solutions

United StatesFounded 2007

  • Neuromodulation
  • Depression

Mindful Health Solutions is an outpatient psychiatric care provider specializing in treatment-resistant depression and other mental health conditions. Its clinicians offer personalized care that combines medication management with interventional treatments such as TMS, SPRAVATO (esketamine), and IV ketamine across clinics in California, Texas, and Washington.

Open roles
13
Posted last 30 days
10
Raised
$5.4M
Investors
3
Founded
2007

reccy insights

Recent highlights

On Aug 20, 2026, Radial announced its acquisition of Mindful Health Solutions. The announcement positions the company within a broader brain-medicine clinical network; related coverage described a 27-clinic network with more than 100 clinicians. The acquisition is a major ownership and scale milestone, although no transaction value was disclosed. In 2025, Mindful Health Solutions announced a collaboration with Sohar Health to use its verification solution to support the patient experience. The company was also reported to be hiring psychiatrists and medical directors during 2025. Earlier, on Oct 1, 2024, it announced a CEO hire from the PE-backed dental-services sector; Meghan Herwehe is listed as CEO, with a 2024 start date. The company’s clinical offering includes TMS, SPRAVATO (esketamine), ketamine infusion therapy, and medication management. Taken together, the acquisition and operational announcements point to continued expansion of a specialized outpatient psychiatry model, while available public information does not disclose the acquisition terms or quantified operating results.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Open roles13

10 roles posted in the last 30 days

  1. 0Jun
  2. 0Jul
  3. 0Aug
  4. 0Sep
  5. 9Oct
  6. 3Nov
Hiring focus

Psychiatrists and medical directors.

Hiring news

Actively hiring psychiatrists and medical directors, with multiple new-hire announcements during 2025.

What makes Mindful Health Solutions distinct

  1. 01Specializes in treatment-resistant depression and interventional psychiatry.
  2. 02Combines TMS, SPRAVATO (esketamine), and IV ketamine with medication management and telepsychiatry.
  3. 03Operates 21 outpatient clinics across California, Texas, and Washington.
  4. 04Uses clinical outcomes from more than 50,000 patients and 300,000 visits to inform care and treatment-outcome prediction.
  5. 05Supports patients with insurance benefits, pre-authorization, and financing.

Technology & products4

  • Transcranial Magnetic Stimulation (TMS)

    A non-invasive procedure using magnetic pulses to stimulate brain regions involved in mood regulation, primarily for treatment-resistant depression and other psychiatric conditions.

  • SPRAVATO (Esketamine)

    An FDA-approved nasal spray medication for patients with depression unresponsive to traditional antidepressants, designed to reduce depressive symptoms by promoting new neural connections.

  • Ketamine Infusion Therapy

    An intravenous treatment intended to provide rapid improvement in symptoms of treatment-resistant depression, PTSD, and other psychiatric conditions.

In the Cortex

Funding

$5.4M disclosed
  • Venture RoundJan 2024
  • Venture RoundOct 2021
    CIBC Innovation Banking, Norwest
  • Venture RoundOct 2017
    $5.4M
3 investors

Similar companies

About Mindful Health Solutions

Products
Transcranial Magnetic Stimulation (TMS), SPRAVATO (Esketamine), Ketamine Infusion Therapy, General Medication Management
Leadership
Ara Chackerian, Co-Founder and Board MemberBrad Hummel, Co-Founder, Board MemberRichard Bermudes, Chief Medical OfficerMeghan Herwehe, CEO
Focus areas
Mental health, psychiatry, treatment-resistant depression, transcranial magnetic stimulation, esketamine, ketamine therapy, outpatient care, telepsychiatry
Headquarters
United States
Founded
2007
Employees
101–250